Global AI-Enabled Drug Discovery and Clinical Trials Market is estimated to be 0.4 Billion by 2029

PUNE, India - July 23, 2021 - PRLog -- The global AI-enabled drug discovery and clinical trials market accounted for US$ 0.4 billion in 2020 and is estimated to be 4.34 billion by 2029 and is anticipated to register a CAGR of 30.7%. The report. "Global AI-Enabled Drug Discovery and Clinical Trials Market, By Components (Solutions and Services), By Solution (Aggregation & Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research, and Others), By Application (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases Immunologic Diseases, Infectious Diseases, and Others), By End-user (Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030".

Analyst View:

AI is helping companies in manipulating huge patient datasets into digestible, identifying personalized, precision medicine opportunities, tangible information, or potential forecasting responses to new drugs. In addition, examining the electronic medical reports of patients, rising applications of AI to analyze the pool of potential subjects in drug discovery, and genomic data for improved clinical trial matching will support to the growth of AI-enabled drug discovery and clinical trials market. Furthermore, the growth in the application of AI in drug discovery aids from the open-source execution will drive the global AI-enabled drug discovery and clinical trial market over the forecast period. AI provides accelerating the treatment options for rare diseases, detects potential rare diseases indications and forecasts new indications for existing medicines. Moreover, increasing adoption of Ai in the pharmacy industry for target discovery, compound screening, compound synthesis, patient recruitment, crystal form prediction, optimization of clinical trial design, and drug redirection will boost the AI-enabled drug discovery and clinical trials in the coming years.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-AI-Enabled-Drug-Discovery-and-Clinical-Trials-Market-4296

Key Topics Covered

1. Introduction

• Study Deliverables
• Study Assumptions
• Scope of the Study

1. Research Methodology
2. Executive Summary

• Opportunity Map Analysis
• Market at Glance
• Market Share (%) and BPS Analysis, by Region
• Competitive Landscape
• Heat Map Analysis
• Market Presence and Specificity Analysis

1. Investment Analysis
2. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com